- Home
- IMNM vs ELMD Comparison
IMNM vs ELMD Comparison
Compare IMNM & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- ELMD
- Stock Information
- Founded
- IMNM 2006
- ELMD 1992
- Country
- IMNM United States
- ELMD United States
- Employees
- IMNM N/A
- ELMD N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IMNM Health Care
- ELMD Health Care
- Exchange
- IMNM Nasdaq
- ELMD Nasdaq
- Market Cap
- IMNM 945.8M
- ELMD 206.5M
- IPO Year
- IMNM 2020
- ELMD 2010
- Fundamental
- Price
- IMNM $9.17
- ELMD $24.44
- Analyst Decision
- IMNM Strong Buy
- ELMD Strong Buy
- Analyst Count
- IMNM 8
- ELMD 2
- Target Price
- IMNM $24.75
- ELMD $35.50
- AVG Volume (30 Days)
- IMNM 1.1M
- ELMD 103.0K
- Earning Date
- IMNM 11-12-2025
- ELMD 11-11-2025
- Dividend Yield
- IMNM N/A
- ELMD N/A
- EPS Growth
- IMNM N/A
- ELMD 46.55
- EPS
- IMNM N/A
- ELMD 0.85
- Revenue
- IMNM $12,589,000.00
- ELMD $64,000,000.00
- Revenue This Year
- IMNM N/A
- ELMD $14.47
- Revenue Next Year
- IMNM $154.73
- ELMD $10.33
- P/E Ratio
- IMNM N/A
- ELMD $28.80
- Revenue Growth
- IMNM 16.74
- ELMD 16.97
- 52 Week Low
- IMNM $5.15
- ELMD $17.73
- 52 Week High
- IMNM $16.55
- ELMD $35.56
- Technical
- Relative Strength Index (RSI)
- IMNM 45.08
- ELMD 57.28
- Support Level
- IMNM $8.93
- ELMD $23.98
- Resistance Level
- IMNM $9.63
- ELMD $24.92
- Average True Range (ATR)
- IMNM 0.70
- ELMD 1.08
- MACD
- IMNM -0.06
- ELMD -0.14
- Stochastic Oscillator
- IMNM 25.19
- ELMD 27.87
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.